211 related articles for article (PubMed ID: 24751211)
1. 14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage.
Maksymowych WP; van der Heijde D; Allaart CF; Landewé R; Boire G; Tak PP; Gui Y; Ghahary A; Kilani R; Marotta A
Arthritis Res Ther; 2014 Apr; 16(2):R99. PubMed ID: 24751211
[TBL] [Abstract][Full Text] [Related]
2. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3η: a novel biomarker platform for rheumatoid arthritis.
Maksymowych WP; Marotta A
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-35-9. PubMed ID: 25365087
[TBL] [Abstract][Full Text] [Related]
4. Serum 14-3-3η Could Improve the Diagnostic Rate of Rheumatoid Arthritis and Correlates to Disease Activity.
Guan SZ; Yang YQ; Bai X; Wang Y; Feng KQ; Zhang HJ; Dong M; Yang HW; Li HQ
Ann Clin Lab Sci; 2019 Jan; 49(1):57-62. PubMed ID: 30814078
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3η Protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritis.
Hammam N; Salah S; Kholef EF; Moussa EM; Marotta A
Mod Rheumatol; 2020 Jul; 30(4):664-670. PubMed ID: 31242798
[No Abstract] [Full Text] [Related]
6. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
Carrier N; Marotta A; de Brum-Fernandes AJ; Liang P; Masetto A; Ménard HA; Maksymowych WP; Boire G
Arthritis Res Ther; 2016 Feb; 18():37. PubMed ID: 26832367
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Serum Protein 14-3-3η (Eta) as a Novel Biomarker for Rheumatoid Arthritis.
El-Sherif WT; Nigm DA; Abd-Elsamea MH; Kassem AM
Egypt J Immunol; 2019 Jan; 26(1):163-175. PubMed ID: 31333006
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D
Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016
[TBL] [Abstract][Full Text] [Related]
9. Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.
Carrier N; de Brum-Fernandes AJ; Liang P; Masetto A; Roux S; Biln NK; Maksymowych WP; Boire G
RMD Open; 2020 May; 6(1):. PubMed ID: 32371434
[TBL] [Abstract][Full Text] [Related]
10. The significance of serum 14-3-3η level in rheumatoid arthritis patients.
Hussin DAAH; Shaat RM; Metwally SS; Awad M
Clin Rheumatol; 2021 Jun; 40(6):2193-2202. PubMed ID: 33400046
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis.
Shovman O; Gilburd B; Watad A; Amital H; Langevitz P; Bragazzi NL; Adawi M; Perez D; Bornstein G; Grossman C; Lidar M; Blank M; Azuri J; Biln NK; Marotta A; Shoenfeld Y
Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):610-617. PubMed ID: 31174829
[TBL] [Abstract][Full Text] [Related]
12. Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
Raft MB; Hetland ML; Brahe CH; Hørslev-Petersen K; Midtbøll Ørnbjerg L; Junker P; Biln N; Stengaard-Pedersen K; Østergaard M
Scand J Rheumatol; 2023 Jul; 52(4):342-352. PubMed ID: 35833274
[TBL] [Abstract][Full Text] [Related]
13. Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.
Hirata S; Marotta A; Gui Y; Hanami K; Tanaka Y
Arthritis Res Ther; 2015 Oct; 17():280. PubMed ID: 26449724
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.
Maksymowych WP; Boire G; van Schaardenburg D; Wichuk S; Turk S; Boers M; Siminovitch KA; Bykerk V; Keystone E; Tak PP; van Kuijk AW; Landewé R; van der Heijde D; Murphy M; Marotta A
J Rheumatol; 2015 Sep; 42(9):1587-94. PubMed ID: 26178283
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3η Protein in Rheumatoid Arthritis: Promising Diagnostic Marker and Independent Risk Factor for Osteoporosis.
Zeng T; Tan L; Wu Y; Yu J
Lab Med; 2020 Sep; 51(5):529-539. PubMed ID: 32080735
[TBL] [Abstract][Full Text] [Related]
16. Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.
Shovman O; Gilburd B; Watad A; Amital H; Langevitz P; Bragazzi NL; Adawi M; Perez D; Lidar M; Katz I; Blank M; Biln NK; Marotta A; Shoenfeld Y
Pharmacol Res; 2019 Mar; 141():623-626. PubMed ID: 30414892
[TBL] [Abstract][Full Text] [Related]
17. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
Graudal N
Scand J Rheumatol Suppl; 2004; 118():1-38. PubMed ID: 15180092
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic values of serum IL-10 and IL-17 in rheumatoid arthritis and their correlation with serum 14-3-3η protein.
Qu CH; Hou Y; Bi YF; Han QR; Jiao CH; Zou QF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1899-1906. PubMed ID: 30915732
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum 14-3-3η protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population.
Gong X; Xu SQ; Wu Y; Ma CC; Qi S; Liu W; Xu JH
Clin Rheumatol; 2017 Nov; 36(11):2581-2587. PubMed ID: 28875246
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of 14-3-3η and anti-carbamylated protein antibodies in Rheumatoid Arthritis in Han population of Northern China.
Zhang Y; Liang Y; Feng L; Cui L
Clin Chim Acta; 2020 Mar; 502():102-110. PubMed ID: 31862264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
